Philip C Taylor, MD | |
3615 Chestnut Street, Philadelphia, PA 19104 | |
(215) 662-2746 | |
(610) 387-4526 |
Full Name | Philip C Taylor |
---|---|
Gender | Male |
Speciality | Internal Medicine - Geriatric Medicine |
Location | 3615 Chestnut Street, Philadelphia, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1942244843 | NPI | - | NPPES |
TA161829 | Other | HIGHMARK BLUE SHIELD | |
0045875000 | Other | KEYSTONE | |
0045875002 | Other | BCBS HIGHMARK KEYSTONE | |
0008866080006 | Medicaid | PA | |
04-32948 | Other | EVERCARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0300X | Internal Medicine - Geriatric Medicine | MD023260E (Pennsylvania) | Primary |
207R00000X | Internal Medicine | MD023260E (Pennsylvania) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Philip C Taylor, MD 3615 Chestnut Street, Philadelphia, PA 19104 Ph: (215) 662-2746 | Philip C Taylor, MD 3615 Chestnut Street, Philadelphia, PA 19104 Ph: (215) 662-2746 |
News Archive
Use of a novel approach to analyzing brain structure that focuses on the shape rather than the size of particular features may allow identification of individuals in early presymptomatic stages of Alzheimer's disease.
The U.S. Food and Drug Administration announced today actions to provide important information about the risks of using Essure and to help women and their doctors be better informed of the potential complications associated with implantable forms of sterilization.
Psychemedics Corporation today announced second quarter financial results for the period ended June 30, 2014. The Company also announced a quarterly dividend of $0.15 per share payable to shareholders of record as of August 7, 2014 to be paid on August 18, 2014.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today reported financial results for the twelve months ended December 31, 2009, and affirmed its 2010 milestones of commencing up to five Phase 2 clinical trials with its oncology drug candidates.
International Partnership for Microbicides (IPM) today announced that it has reached a farsighted agreement with Tibotec Pharmaceuticals Ltd, a subsidiary of Johnson & Johnson. The aim is to develop the promising compound TMC120 as a safe and effective microbicide to help protect women from infection with HIV. This agreement marks the first collaboration in the microbicide field between a major healthcare company and a public-private partnership such as IPM.
› Verified 7 days ago
Philippe Olivier Szapary, MD Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 3400 Civic Center Blvd, East Pavilion, 2nd Floor, Philadelphia, PA 19104 Phone: 215-615-4949 | |
Dr. Jamie L. Garfield, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 3401 N Broad St, Philadelphia, PA 19140 Phone: 215-707-5864 Fax: 215-707-6867 | |
Maria Esther Escorcia De Leon, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 3401 N Broad St, Philadelphia, PA 19140 Phone: 215-707-1622 Fax: 215-707-0943 | |
Cherag Daruwala, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 2301 E Allegheny Ave, Suite 190b, Philadelphia, PA 19134 Phone: 215-926-3120 Fax: 215-926-3123 | |
Dr. Robert Burke, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 51 N 39th St, Philadelphia, PA 19104 Phone: 215-662-9436 Fax: 215-243-3208 | |
Eva Hassan Alsheik, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 219 N Broad St, 5th Floor, Philadelphia, PA 19107 Phone: 215-762-6071 | |
Dr. Jason Thomas Ackrivo, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 3400 Spruce St, Philadelphia, PA 19104 Phone: 215-614-0871 |